Hosted on MSN1mon
Innovate Corp. stock soars on FDA approval
Investing.com -- Shares of Innovate Corp. (NYSE:VATE) surged 60% following the announcement that the U.S. Food and Drug Administration (FDA) has approved the company's MediBeacon Transdermal GFR ...
Nature5y
Cystatin C is not an unbiased marker of GFR
Serum cystatin C levels are influenced by factors other than glomerular filtration rate (GFR), a retrospective analysis suggests. Serum concentration of cystatin C has been proposed as a more ...